Oral anticoagulation for secondary prevention after myocardial infarction with special reference to the warfarin re-infarction study

Prog Cardiovasc Dis. 1992 Mar-Apr;34(5):317-22. doi: 10.1016/0033-0620(92)90037-z.
No abstract available

Publication types

  • Meta-Analysis

MeSH terms

  • Administration, Oral
  • Anticoagulants / administration & dosage*
  • Humans
  • Meta-Analysis as Topic
  • Myocardial Infarction / complications
  • Myocardial Infarction / drug therapy*
  • Recurrence
  • Warfarin / administration & dosage*

Substances

  • Anticoagulants
  • Warfarin